{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T18:59:37Z","timestamp":1784919577798,"version":"3.55.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.bpobgyn.2010.02.006","type":"journal-article","created":{"date-parts":[[2010,4,26]],"date-time":"2010-04-26T08:47:58Z","timestamp":1272271678000},"page":"503-516","source":"Crossref","is-referenced-by-count":20,"title":["Medical and surgical options for induced abortion in first trimester"],"prefix":"10.1016","volume":"24","author":[{"given":"Haitham","family":"Hamoda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Templeton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2010.02.006_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/beog.2001.0272","article-title":"Medical abortion in the first trimester","volume":"16","author":"Baird","year":"2002","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/humrep\/17.2.332","article-title":"Pharmacokinetics of different routes of administration of misoprostol","volume":"17","author":"Tang","year":"2002","journal-title":"Hum Reprod"},{"issue":"8","key":"10.1016\/j.bpobgyn.2010.02.006_bib4","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/humrep\/dep108","article-title":"Pharmacokinetics of repeated doses of misoprostol","volume":"24","author":"Tang","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/humrep\/deh005","article-title":"Effects of misoprostol on uterine contractility following different routes of administration","volume":"19","author":"Aronsson","year":"2004","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.bpobgyn.2010.02.006_bib6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijgo.2006.09.009","article-title":"Alternatives to mifepristone for early medical abortion","volume":"96","author":"Moreno-Ruiz","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib7","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/humrep\/17.6.1477","article-title":"A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy","volume":"17","author":"Jain","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib8","author":"Gynuity Health Projects"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1471-0528.1988.tb06840.x","article-title":"The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin","volume":"95","author":"Swahn","year":"1988","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib10","unstructured":"Schaff EA. Mifepristone: ten years later. Contracetion in press."},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/338110d0","article-title":"RU 486 abortions","volume":"338","author":"Henrion","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0140-6736(05)60300-5","article-title":"Fetal malformation and failed medical termination of pregnancy","volume":"352","author":"Sitruk-Ware","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib13","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/HUMREP\/10.6.1521","article-title":"Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion","volume":"10","author":"Baird","year":"1995","journal-title":"Hum Reprod"},{"issue":"10","key":"10.1016\/j.bpobgyn.2010.02.006_bib14","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/humrep\/16.10.2098","article-title":"Double blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation","volume":"16","author":"Bartley","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib15","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM199504133321502","article-title":"Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol","volume":"332","author":"El Refaey","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib16","author":"Mifegyne (mifepristone)"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib17","isbn-type":"print","article-title":"The care of women requesting induced abortion","volume":"vol. 7","author":"Royal College of Obstetricians and Gynaecologists","year":"2004","ISBN":"https:\/\/id.crossref.org\/isbn\/1904752063"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002855.pub3","article-title":"Medical methods for first trimester abortion","author":"Kulier","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.bpobgyn.2010.02.006_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.contraception.2009.01.011","article-title":"Meta-analysis of 200 or 600mg mifepristone in association with two prostaglandins for termination of early pregnancy","volume":"80","author":"Lievre","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib20","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1046\/j.1471-0528.2002.02156.x","article-title":"Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases","volume":"109","author":"Ashok","year":"2002","journal-title":"Br J Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2010.02.006_bib21","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/01.AOG.0000258298.35143.d2","article-title":"Mifepristone and misoprostol administered simultaneously versus 24h apart for abortion: a randomized controlled trial","volume":"109","author":"Creinin","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2010.02.006_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1471-0528.2006.01179.x","article-title":"Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48h protocol","volume":"114","author":"Guest","year":"2007","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib23","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/humrep\/deg475","article-title":"A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation","volume":"18","author":"Tang","year":"2003","journal-title":"Hum Reprod"},{"issue":"8","key":"10.1016\/j.bpobgyn.2010.02.006_bib24","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1471-0528.2005.00638.x","article-title":"A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks gestation","volume":"112","author":"Hamoda","year":"2005","journal-title":"Br J Obstet Gynaecol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2010.02.006_bib25","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/AOG.0b013e31818d8eb4","article-title":"Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial","volume":"112","author":"Winikoff","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib26","series-title":"Abortion statistics. Statistical bulletin 2009\/1","author":"Department of Health","year":"2008"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/humrep\/17.1.92","article-title":"A randomized comparison of medical abortion and surgical vacuum aspiration at 10\u201313 weeks gestation","volume":"17","author":"Ashok","year":"2002","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.bpobgyn.2010.02.006_bib28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.contraception.2004.10.015","article-title":"Uptake and efficacy of medical abortion at 9\u201313 weeks gestation: review of 1076 consecutive cases","volume":"71","author":"Hamoda","year":"2005","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.bpobgyn.2010.02.006_bib29","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/01.AOG.0000259319.18958.76","article-title":"Mifepristone followed in 24h to 48h by misoprostol for late first-trimester abortion","volume":"109","author":"Bracken","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib30","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0029-7844(02)01944-0","article-title":"Comparison of abortions induced by methotrexate or mifepristone followed by misoprostol","volume":"99","author":"Wiebe","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0010-7824(97)00020-6","article-title":"The use of misoprostol for termination of early pregnancy","volume":"55","author":"Carbonell","year":"1997","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.bpobgyn.2010.02.006_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.contraception.2006.03.029","article-title":"Frequently asked questions about medical abortion","volume":"74","author":"von Hertzen","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.contraception.2004.04.009","article-title":"Infection after medical abortion: a review of the literature","volume":"70","author":"Shannon","year":"2004","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.bpobgyn.2010.02.006_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa0809146","article-title":"Rates of serious infection after changes in regimens for medical abortion","volume":"361","author":"Fjerstad","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0010-7824(00)00187-6","article-title":"Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost","volume":"62","author":"Bartley","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib36","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S0140-6736(97)12363-7","article-title":"Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy","volume":"351","author":"Gonzalez","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib37","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2307\/2136257","article-title":"Acceptability of medical abortion in early pregnancy","volume":"27","author":"Winikoff","year":"1995","journal-title":"Fam Plann Perspect"},{"issue":"6","key":"10.1016\/j.bpobgyn.2010.02.006_bib38","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1471-0528.2004.00538.x","article-title":"The acceptability of home medical abortion to women in UK settings","volume":"112","author":"Hamoda","year":"2005","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0010-7824(00)00090-1","article-title":"Predictors of analgesia use during supervised medical abortion","volume":"61","author":"Westhoff","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib40","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0010-7824(00)00186-4","article-title":"Analgesia during at-home use of misoprostol as part of a medical abortion regimen","volume":"62","author":"Westhoff","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib41","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1001\/jama.284.15.1948","article-title":"Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: a randomized trial","volume":"284","author":"Schaff","year":"2000","journal-title":"J Am Med Assoc"},{"issue":"3","key":"10.1016\/j.bpobgyn.2010.02.006_bib42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1783\/1471189054483915","article-title":"Home self-administration of misoprostol for medical abortion up to 56 days gestation","volume":"31","author":"Hamoda","year":"2005","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"3","key":"10.1016\/j.bpobgyn.2010.02.006_bib43","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/13625180500284581","article-title":"Home use of two doses of misoprostol after mifepristone for medical abortion: a pilot study in Sweden and France","volume":"10","author":"Clark","year":"2005","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib44","series-title":"Surgical abortion: history and overview","author":"National Abortion Federation","year":"2009"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00006254-197903000-00001","article-title":"Complications from legally-induced abortion: a review","volume":"34","author":"Grimes","year":"1979","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib46","first-page":"364","article-title":"Abortion: methods and sequelae","volume":"28","author":"Savage","year":"1982","journal-title":"Br J Hosp Med"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib47","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/0002-9378(79)90731-2","article-title":"Local versus general anesthesia: which is safer for performing suction curettage abortions?","volume":"135","author":"Grimes","year":"1979","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib48","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0020-7292(00)00292-7","article-title":"Comparison of paracervical block techniques during first trimester pregnancy termination","volume":"72","author":"Glantz","year":"2001","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib49","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1067\/mob.2002.123734","article-title":"Paracervical block and elective abortion: the effect on pain of waiting between injection and procedure","volume":"186","author":"Phair","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib50","unstructured":"Department of Health. Conscious sedation in termination of pregnancy. Report of the DoH Expert Group 2002. Crown Copyright."},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib51","first-page":"6","article-title":"Early abortion: surgical and medical options","volume":"20","author":"Edward","year":"1997","journal-title":"Cur Prob Obstet Gynecol Fert"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib52","series-title":"Manual vacuum aspiration: expanding women\u2019s access to safe abortion services","author":"Baird","year":"2001"},{"issue":"1","key":"10.1016\/j.bpobgyn.2010.02.006_bib53","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1471-0528.2007.01572.x","article-title":"Manual versus electric vacuum aspiration for first-trimester abortion: a systematic review","volume":"115","author":"Wen","year":"2008","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib54","series-title":"Safe abortion. Technical and policy guidance for health systems","author":"WHO","year":"2003"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib55","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0140-6736(94)92406-6","article-title":"Cervical priming with prostaglandin E1 analogues, misoprostol and gemeprost","volume":"343","author":"El Refaey","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib56","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0029-7844(98)00281-6","article-title":"Randomized trial to determine optimal dose of vaginal misoprostol for preabortion cervical priming","volume":"92","author":"Singh","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib57","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1471-0528.1999.tb08241.x","article-title":"Vaginal misoprostol for pre-abortion cervical priming: is there an optimal evacuation time interval?","volume":"106","author":"Singh","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib58","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/ejc.6.3.134.140","article-title":"Oral versus vaginal misoprostol for cervical priming in first-trimester abortion: a randomized trial","volume":"6","author":"Carbonell","year":"2001","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"1","key":"10.1016\/j.bpobgyn.2010.02.006_bib59","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ajog.2003.08.025","article-title":"A randomised controlled trial of sublingual and vaginal administration of misoprostol for cervical priming prior to first-trimester surgical abortion","volume":"190","author":"Hamoda","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2010.02.006_bib60","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1067\/mob.2000.106767","article-title":"Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study","volume":"183","author":"Ashok","year":"2000","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2010.02.006_bib61","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1471-0528.1997.tb12028.x","article-title":"Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial","volume":"104","author":"Howie","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2010.02.006_bib62","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1093\/oxfordjournals.humrep.a138412","article-title":"A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae","volume":"9","author":"Henshaw","year":"1994","journal-title":"Hum Reprod"},{"issue":"6906","key":"10.1016\/j.bpobgyn.2010.02.006_bib63","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/bmj.307.6906.714","article-title":"Comparison of medical abortion with surgical vacuum aspiration: women\u2019s preferences and acceptability of treatment","volume":"307","author":"Henshaw","year":"1993","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.bpobgyn.2010.02.006_bib64","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.contraception.2004.08.013","article-title":"Patient preference in a randomized study comparing medical and surgical abortion at 10\u201313 weeks gestation","volume":"71","author":"Ashok","year":"2005","journal-title":"Contraception"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693410000210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693410000210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:49:55Z","timestamp":1559069395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693410000210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S1521693410000210"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2010.02.006","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}